ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,024
Screening encounters
3,451
Diagnostic referrals
654
Outstanding pathways
243

Screening pathway

  1. Screening3,451Encounters
  2. Positive finding1,182Documented findings
  3. Referral654Diagnostic referrals
  4. Follow-up770Diagnostic visits
  5. Outcome411Resolved pathways

Stage totals use different units. Pending pathways: 243. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2899 · EXP-2899Synthetic · Site D

Full participant history through 2026-06-25, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-07-26
  4. · Diagnostic referral · EXP-2899-T-R
  5. · Contact attempt · Unsuccessful
  6. · Contact attempt · Reached
  7. · Diagnostic booking · Initial booking
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Diagnosis · Histopathology · No high-grade lesion identified
  11. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-03-30
  12. · Follow-up disposition · Resolved · EXP-2899-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3024 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3185 · Expanded synthetic participant 3185Site A — Urban Referral Hub
EXP-3186 · Expanded synthetic participant 3186Site A — Urban Referral Hub
EXP-3189 · Expanded synthetic participant 3189Site E — Resource-Constrained Navigation Programme
EXP-3190 · Expanded synthetic participant 3190Site B — Peri-Urban Access Programme
EXP-3192 · Expanded synthetic participant 3192Site E — Resource-Constrained Navigation Programme
EXP-3193 · Expanded synthetic participant 3193Site B — Peri-Urban Access Programme
EXP-3195 · Expanded synthetic participant 3195Site B — Peri-Urban Access Programme
EXP-3196 · Expanded synthetic participant 3196Site C — Rural Outreach Programme
EXP-3200 · Expanded synthetic participant 3200Site A — Urban Referral Hub
EXP-3201 · Expanded synthetic participant 3201Site B — Peri-Urban Access Programme
EXP-3202 · Expanded synthetic participant 3202Site E — Resource-Constrained Navigation Programme
EXP-3203 · Expanded synthetic participant 3203Site D — Community Engagement Programme
EXP-3206 · Expanded synthetic participant 3206Site B — Peri-Urban Access Programme
EXP-3209 · Expanded synthetic participant 3209Site B — Peri-Urban Access Programme
EXP-3210 · Expanded synthetic participant 3210Site B — Peri-Urban Access Programme
EXP-3212 · Expanded synthetic participant 3212Site D — Community Engagement Programme
EXP-3213 · Expanded synthetic participant 3213Site A — Urban Referral Hub
EXP-3216 · Expanded synthetic participant 3216Site D — Community Engagement Programme
EXP-3219 · Expanded synthetic participant 3219Site C — Rural Outreach Programme
EXP-3220 · Expanded synthetic participant 3220Site C — Rural Outreach Programme
EXP-3221 · Expanded synthetic participant 3221Site E — Resource-Constrained Navigation Programme
EXP-3223 · Expanded synthetic participant 3223Site D — Community Engagement Programme
EXP-3224 · Expanded synthetic participant 3224Site E — Resource-Constrained Navigation Programme
EXP-3225 · Expanded synthetic participant 3225Site A — Urban Referral Hub
EXP-3226 · Expanded synthetic participant 3226Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1384
HPV DNA
1565
Cytology
502

Navigation activity

Barrier documented
558
Contact attempt
964
Navigation intervention
241
Diagnostic booking
812
Diagnostic visit
770

Documented barriers

Contact difficulty
182
Transport difficulty
174
Appointment coordination
202

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.